Immunic, Inc. short interest in 2024
In 2024, Immunic, Inc.'s disclosed short interest ran from 7.22% of shares outstanding on 12 Jan 2024 to 6.27% on 31 Dec 2024, a change of -0.95 percentage points. The year's high was 7.22% on 12 Jan 2024 and its low 2.59% on 30 Aug 2024, averaging 4.54% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.51 days on 15 May 2024. Full history: Immunic, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 7.22% (12 Jan 2024)
- End of year
- 6.27% (31 Dec 2024)
- Change
- -0.95 pp
- High
- 7.22% (12 Jan 2024)
- Low
- 2.59% (30 Aug 2024)
- Average
- 4.54%
- Highest days to cover
- 17.51 (15 May 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 7.22% | 1.19 | |
| 31 Jan 2024 | 5.75% | 2.87 | |
| 15 Feb 2024 | 5.59% | 4.00 | |
| 29 Feb 2024 | 4.92% | 2.54 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 5.48% | 3.08 | |
| 28 Mar 2024 | 6.71% | 11.84 | |
| 15 Apr 2024 | 6.37% | 9.45 | |
| 30 Apr 2024 | 6.25% | 12.84 | |
| 15 May 2024 | 3.13% | 17.51 | 10-Q filed, results (8-K) |
| 31 May 2024 | 4.21% | 14.42 | |
| 14 Jun 2024 | 3.29% | 17.42 | |
| 28 Jun 2024 | 3.34% | 8.82 | |
| 15 Jul 2024 | 3.28% | 7.94 | |
| 31 Jul 2024 | 2.99% | 7.30 | |
| 15 Aug 2024 | 2.79% | 11.48 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 2.59% | 7.06 | |
| 13 Sep 2024 | 2.61% | 11.21 | |
| 30 Sep 2024 | 2.98% | 3.15 | |
| 15 Oct 2024 | 3.85% | 10.82 | |
| 31 Oct 2024 | 4.99% | 2.88 | |
| 15 Nov 2024 | 4.21% | 3.68 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 4.66% | 5.84 | |
| 13 Dec 2024 | 5.45% | 6.27 | |
| 31 Dec 2024 | 6.27% | 6.23 |
See also: Immunic, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.